These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 14628647

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies.
    Elkayam O, Paran D, Burke M, Zakut V, Ben-Yitshak R, Litinsky I, Caspi D.
    Autoimmunity; 2005 Nov; 38(7):493-6. PubMed ID: 16373254
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus.
    Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, Rubins JB.
    Clin Infect Dis; 2002 Jan 15; 34(2):147-53. PubMed ID: 11740700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antibody response to pneumococcal capsular polysaccharide vaccination in patients with chronic kidney disease.
    Mahmoodi M, Aghamohammadi A, Rezaei N, Lessan-Pezeshki M, Pourmand G, Mohagheghi MA, Abdollahzade S, Mousavi-Jarrahi A.
    Eur Cytokine Netw; 2009 Jun 15; 20(2):69-74. PubMed ID: 19541592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.
    Togashi T, Yamaji M, Thompson A, Giardina PC, Aizawa M, Patterson S, Gruber WC, Scott DA, 3003 Study Group.
    Pediatr Infect Dis J; 2013 Sep 15; 32(9):984-9. PubMed ID: 23538524
    [Abstract] [Full Text] [Related]

  • 11. Fold-increase in antibody titer upon vaccination with pneumococcal unconjugated polysaccharide vaccine.
    Borgers H, Meyts I, De Boeck K, Raes M, Sauer K, Proesmans M, Moens L, Jeurissen A, Flamaing J, Peetermans WE, Verhaegen J, Bossuyt X.
    Clin Immunol; 2012 Nov 15; 145(2):136-8. PubMed ID: 23026475
    [No Abstract] [Full Text] [Related]

  • 12. Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
    Hafraoui K, Moutschen M, Smet J, Mascart F, Schaaf-Lafontaine N, Fillet G.
    Eur J Intern Med; 2009 May 15; 20(3):e62-5. PubMed ID: 19393481
    [Abstract] [Full Text] [Related]

  • 13. A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus.
    Chatham W, Chadha A, Fettiplace J, Kleoudis C, Bass D, Roth D, Gordon D.
    Lupus; 2017 Dec 15; 26(14):1483-1490. PubMed ID: 28467293
    [Abstract] [Full Text] [Related]

  • 14. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus.
    McDonald E, Jarrett MP, Schiffman G, Grayzel AI.
    J Rheumatol; 1984 Jun 15; 11(3):306-8. PubMed ID: 6737372
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children.
    Espinosa-Padilla SE, Murata C, Estrada-Parra S, Santos-Argumedo L, Mascareñas C, Franco-Paredes C, Espinosa-Rosales FJ.
    Arch Med Res; 2012 Jul 15; 43(5):402-5. PubMed ID: 22868187
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistence of antibody response to pneumococcal capsular polysaccharides in vaccinated long term-care residents in Brazil.
    Brandão AP, de Oliveira TC, de Cunto Brandileone MC, Gonçalves JE, Yara TI, Simonsen V.
    Vaccine; 2004 Dec 21; 23(6):762-8. PubMed ID: 15542200
    [Abstract] [Full Text] [Related]

  • 19. Anamnestic immune response in 3- to 4-year-old children previously immunized with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine as 2-dose or 3-dose priming and a booster dose in the first year of life.
    Silfverdal SA, Skerlikova H, Zanova M, Papúchová D, Traskine M, Borys D, Schuerman L.
    Pediatr Infect Dis J; 2011 Sep 21; 30(9):e155-63. PubMed ID: 21572373
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.